Stifel Resumes National Health Investors (NHI) at Hold
Tweet
Share
E-mailGet Alerts NHI Hot Sheet
Price: $73.41 --0%
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 14
Rating Summary:
8 Buy, 7 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 14
Join SI Premium – FREE
Stifel analyst Stephen Manaker resumes coverage on National Health Investors (NYSE: NHI) with a Hold rating and a price target of $63.00.
For an analyst ratings summary and ratings history on National Health Investors click here. For more ratings news on National Health Investors click here.
Shares of National Health Investors closed at $62.25 yesterday.
You May Also Be Interested In
- Truist Securities Assumes Corcept Therapeutics (CORT) at Buy
- Morgan Stanley Starts eMemory Technology Inc (3529:TT) at Overweight
- Susquehanna Starts Marriott Vacations Worldwide (VAC) at Neutral
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
